58A
AASLD PROGRAM
HEPATOLOGYOctober 1995
Monday Parallel Sessions 4:36 #467
PRESENTATION OF THE AMERICAN LIVER FOUNDATION P E D I A T R I C F E L L O W S H I P AWARD Presented by: Thomas Boyer Presented to: JWS Fang
4:12 #472
PP Scaglioni, M Melegari, M Takahashi, R Chowdhury and JR Wands. Molecular Hepatol. Lab., Massachusetts Gen. Hosp. Cancer Ctr. and Harvard Med. Sch., Charlestown, MA; Liver Ctr., Albert Einstein College of Med., Bronx, NY.
I d e n t i f i c a t i o n of c r o s s - s u b t y p e ( l a / l b ) B-cell e p i t o p e s w i t h i n E l / E 2 of h e p a t i t i s C virus. JWS Fang, JA Feller, G Martens, M Mizokami, M Kohara and JYN Lau. Univ. of Florida, Gainesville, FL; Innogenetics NV, Ghent, Belgium; Nagoya City Univ., Nagoya and Tokyo Metropolitan Inst. of Med. Science, Tokyo, Japan.
P a r a l l e l S e s s i o n VI Hepatitis B S h e r a t o n C h i c a g o B a l l r o o m VI-VII 3:00-5:00 p m
4:24 #473
4:36 #474
Moderators: Jack R. Wands and T. Jake Liang
3:00 #468
Effect of a n a t i o n w i d e h e p a t i t i s B v a c c i n a t i o n p r o g r a m in a hypere n d e m i c area: a 10-year s e q u e n t i a l s e r o e p i d e m i o l o g i c s t u d y in T a i w a n . M-H Chang, H-L Chen, HY Hsu, YH Ni, P-I Lee, C-Y Lee and D-S Chen. Depts. of Peds. and Internal Med., Nail. Taiwan Univ. Hosp., Taipei, Taiwan.
3:12
#469
V a c c i n e t h e r a p y for h e p a t i t i s B v i r u s (HBV) carriers: a s t u d y i n m u r i n e HBV carriers o n dose, d u r a t i o n a n d prognosis.
L a m i v u d i n e prophylaxis: a n e w s t r a t e g y for p r e v e n t i o n of r e i n f e c t i o n i n liver t r a n s p l a n t a t i o n for h e p a t i t i s B D N A p o s i t i v e cirrhosis. L Grellier, D Brown, P McPhilips, A Burroughs, K Rolles and G Dusheiko. Royal Free Hosp. Sch. of Med., London and Glaxo Research & Development, Middlesex, England.
3:36 #471
3:48
Overview talk. JR Wands. Charlestown, MA.
J zu Putlitz, S Wieland and HE Blum. Dept. of Internal Med. II, Univ. of Freiburg, Germany.
Multimeric self-cleaving ribozyme a g a i n s t h e p a t i t i s B virus. J Ruiz, CH Wu and GY Wu. Dept. of Med., Div. of Gastro.-Hepatol., Univ. of Connecticut Health Ctr., Farmington, CT.
P r e s e n t e d i n c o m m e m o r a t i o n of t h e 25th A n n i v e r s a r y of t h e N a t i o n a l I n s t i t u t e o n Alcohol A b u s e a n d A l c o h o l i s m (NIAAA) Moderators: Lawrence Lumeng and Craig McClain
3:00 #475
Polyenylphosphatidylcholine d e c r e a s e s o x i d a n t stress a n d protects a g a i n s t a l c o h o l - i n d u c e d liver i n j u r y in the b a b o o n . CS Lieber, MA Leo, SI Aleynik, MA Aleynik and LM DeCarli. Section of Liver Disease & Nutrition, Alcohol Research Ctr., Bronx VA Med. Ctr. and Mt. Sinai Sch. of Med., New York, NY.
3:12 #476
Treatment with dietary saturated fatty acids r e d u c e s e n d o t o x e m i a , T N F a m R N A a n d c o l l a g e n in experim e n t a l a l c o h o l i c liver d i s e a s e . AA Nanji, A Rahemtulla, T Daly, S Khwaja, B Griniuviene and AJ Dannenberg. Dept. of Pathol., N.E. Deaconess Hosp. and Harvard Med. Sch., Boston, MA; Dept. of Med., Cornell Med. College and Strang Cancer Prevention Ctr., New York, NY.
R o u t i n e e v a l u a t i o n of h e p a t i t i s B v i r u s replication: w h a t t e c h n i q u e s h o u l d b e r ~d? JM Pawlots~y, A Bastie, J R~mir~, F Darthuy, J Duval and D Dhumeaux. Depts. of Virol. and Hepatol., Hop. Henri Mondor, Univ. Paris XII, Creteil, France.
I n h i b i t i o n of h e p a t i t i s B v i r u s replic a t i o n b y a n t i s e n s e RNA.
Parallel S e s s i o n VII Alcohol S h e r a t o n Chicago B a l l r o o m V I I I - I X 3:00-5:00 p m
SMF Akbar, K Kurose, K Tanimoto, M Masumoto, K Michitaka, N Horike and M Onji. 3rd Dept. of Internal Med., Ehime Univ. Sch. of Med., Ehime, Japan.
3:24 #470
Use of d o m i n a n t n e g a t i v e m u t a n t s of the h e p a d n a v i r a l core p r o t e i n a s antiviral agents.
3:24 #477
Effects of dietary fat o n e t h a n o l i n d u c e d h e p a t i c stellate cell activation. H Tsukamoto, TV Pham, S Cheng and WS Blaner. USC Ctr. for Liver Diseases, USC, Los Angeles and Children's Hosp., Oakland, CA; Inst. of Human Nutrition, College of Physicians & Surg. of Columbia Univ., New York, NY.